TerrAscend (TSNDF) Other Non-Current Assets (2021 - 2026)

TerrAscend's (TSNDF) quarterly Other Non-Current Assets came in at $5.2 million in Q1 2026, up 3002.98% year-on-year from $168000.0 in Q1 2025, and up 8588.33% on a QoQ basis from $60000.0 in Q4 2025.

TerrAscend (TSNDF) Other Non-Current Assets (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Other Non-Current Assets data on file, last reported at $5.2 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 3002.98% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $5.2 million, a 3002.98% increase from a year earlier, with the FY2025 full-year figure at $60000.0, down 91.7% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $5.2 million, up from $60000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for TSNDF reached as high as $5.2 million in Q1 2026 and fell as low as $60000.0 in Q4 2025.
  • Historically, Other Non-Current Assets has averaged $1.4 million across 5 years, with a median of $724000.0 in 2024.
  • Across the five-year window, Other Non-Current Assets tumbled 91.7% in 2025 and soared 3002.98% in 2026, its largest moves.
  • Year by year, Other Non-Current Assets stood at $837000.0 in 2022, then gained by 2.03% to $854000.0 in 2023, then dropped by 15.34% to $723000.0 in 2024, then tumbled by 91.7% to $60000.0 in 2025, then surged by 8588.33% to $5.2 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $5.2 million in Q1 2026, $60000.0 in Q4 2025, and $168000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn 5.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.21 Mn
Dec 31, 2025 60,000.00
Sep 30, 2025 168,000.00
Jun 30, 2025 507,000.00
Mar 31, 2025 168,000.00
Dec 31, 2024 723,000.00
Sep 30, 2024 284,000.00
Jun 30, 2024 724,000.00
Mar 31, 2024 867,000.00
Dec 31, 2023 854,000.00
Sep 30, 2023 426,000.00
Jun 30, 2023 848,000.00
Mar 31, 2023 525,000.00
Dec 31, 2022 837,000.00
Sep 30, 2022 1.46 Mn
Jun 30, 2022 5.00 Mn
Mar 31, 2022 4.82 Mn
Dec 31, 2021 3.14 Mn